Pelvic Cancer Clinical Trials

7 recruiting

Pelvic Cancer Trials at a Glance

8 actively recruiting trials for pelvic cancer are listed on ClinicalTrialsFinder across 6 cities in 10 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Glasgow, Brighton, and Cornwell. Lead sponsors running pelvic cancer studies include M.D. Anderson Cancer Center, Oslo University Hospital, and Glasgow Royal Infirmary.

Browse pelvic cancer trials by phase

About Pelvic Cancer Clinical Trials

Looking for clinical trials for Pelvic Cancer? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Pelvic Cancer trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Pelvic Cancer clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Abdominal CancerPelvic Cancer
M.D. Anderson Cancer Center200 enrolled1 locationNCT00493688
Recruiting

Reconstruction in Extended MArgin Cancer Surgery

Quality of LifeAbdominal CancerPelvic Cancer+1 more
University Hospital Southampton NHS Foundation Trust236 enrolled18 locationsNCT05219058
Recruiting
Not Applicable

Evaluation of On-Couch CBCT Image Quality

Head and Neck CancerThoracic CancerAbdominal Cancer+1 more
Varian, a Siemens Healthineers Company46 enrolled1 locationNCT06576908
Recruiting
Not Applicable

AI as an Aid for Weekly Symptom Intake in Radiotherapy

Radiotherapy Side EffectPatientPelvic Cancer
jaide200 enrolled1 locationNCT06525181
Recruiting

Ultrasound-guided Tru-Cut Biopsy in Pelvic Masses.

Ovarian CancerCervical CancerEndometrial Cancer+6 more
Universitaire Ziekenhuizen KU Leuven200 enrolled4 locationsNCT05610501
Recruiting

Accuracy of Coplanar Template Assisted Seed Implantation for Abdominal and Pelvic Cancer

Accuracy of Coplanar Template Assisted Seed Implantation for Abdominal and Pelvic Cancer
Peking University Third Hospital34 enrolled1 locationNCT05483452
Recruiting
Not Applicable

Laparoscopic Robot-assisted Pelvic Exenteration for Pelvic Primary and Recurrent Cancers

Locally Advanced Pelvic Cancer That Require Pelvic Exenteration
Oslo University Hospital40 enrolled1 locationNCT05186493
Recruiting

Advanced Pelvic Surgical Oncology Database - Prospective Observational Study

Colon CancerRectal CancerGynecologic Cancer+1 more
Glasgow Royal Infirmary300 enrolled1 locationNCT05696002